TMO Trading Analysis - 10/23/2026 02:56 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge headlines and context for Thermo Fisher Scientific (TMO):

• TMO reported steady demand in laboratory products and biopharma services through mid-2026, with management citing resilient academic and clinical spending.
• Company unveiled expanded sterile-fill manufacturing capacity in early October 2026, supporting long-term contract pipeline growth.
• Healthcare equipment sector benefited from easing input-cost pressures, though deflation in certain reagent categories remained a margin watch-item.
• No confirmed near-term earnings date in provided data; last ex-dividend was 2026-09-15 with a $1.88 rate.
• Context: Headlines reflect stable fundamentals, which align with the bullish options flow and strong 50-day SMA trend in the embedded data rather than contradicting it.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

• Trailing P/E is 36.90 and trailing EPS is 18.61; forward P/E, PEG, profit margins, revenue growth, ROE, and debt/equity are null and not available in the data.
• Market cap is $250.94B with 369.75M shares outstanding and a low beta of 0.71 indicating below-market volatility.
• Dividend yield is 0.27% with $1.88 rate; institutional ownership is 66.21%.
• 52-week range is $435.27 to $705.79; current price near the high end of the annual range.
• Historical volatility is 26.75% and average volume is 2.37M shares.
• Analyst consensus and target price are null; no recommendation key provided.
• Fundamentals show large-cap stability with low beta, but absent margin and growth data limits deeper alignment check vs the bullish technical and sentiment picture.

Current Market Position

Current price per indicators is $678.68 (2026-10-22 close). Recent daily action shows a peak close of $696.78 on 2026-10-21 then pullback to $678.68 on 2026-10-22. Minute bars for 2026-10-22 15:55 show closing price drifting from $675.31 to $675.81 on elevated volume of 198,873 in final bar, indicating late-session weakness. Intraday on 2026-10-21 opened $665.00 and reached high $705.79 before settling $696.78.

Technical Analysis

SMA alignment is bullish: 5-day ($686.95) above 20-day ($672.73) above 50-day ($643.66). RSI at 58.04 shows moderate momentum without overbought. MACD positive with histogram 2.58 confirms bullish crossover. Price is inside Bollinger Bands between mid ($672.73) and upper ($701.00). 30-day high is $705.79 and low is $605.65; current $678.68 sits in upper third of range.

True Sentiment Analysis (Delta 40-60 Options)

Options flow sentiment is Bullish. Call dollar volume is $2,066,770 (78.7%) vs put dollar volume $559,960 (21.3%) on 44 true-sentiment contracts. This shows strong directional call conviction.

Call Volume: $2,066,770 (78.7%) Put Volume: $559,960 (21.3%) Total: $2,626,730

Near-term expectations lean bullish, matching the SMA alignment. No divergence from technicals is present in the data.

Key Price Levels (observational only)